{
  "compound": "Medical cannabis/cannabinoids",
  "condition": "ALZHEIMERS",
  "effect_size": "N/A (guideline)",
  "study_type": "CLINICAL_GUIDELINE",
  "source": "NORML:ALZHEIMERS_GUIDELINE_001",
  "participants": "Evidence-based guideline",
  "year": 2019,
  "notes": "Canadian Guidelines for Cannabis in Older Adults with Dementia",
  "confidence": "medium",
  "abstract": "Weak recommendation for cannabinoids in treatment-resistant dementia-related agitation; Start low, go slow; Monitor for sedation/falls"
}